Delivery Order SPE2DB24D2205-SPE2DB25FECMY

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 units of the medication Bidil 20 mg-37.5 mg tablets, with a ceiling value of $4,408.20 and a performance period ending on May 20, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,570.15 and an ultimate completion date of April 16, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across various...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a major defense supply chain management agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract has a ceiling value of $4,955.04 and a completion date of May 30, 2025. It is for the delivery of various pharmaceutical and medical products to support federal agencies, particularly the military and veteran healthcare systems. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,396.92, is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract is not set aside and involves the delivery of a variety of pharmaceutical and medical products, including medications across multiple therapeutic domains such as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,005.32, is a firm fixed-price delivery order with a performance period extending through May 12, 2025. The contract is not set-aside and allows for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $236,099.47 and an ultimate completion date of May 23, 2025. The contract is not set aside and provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains, to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,571.65 and an ultimate completion date of May 13, 2025. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $1,372.60 and a performance period ending on May 16, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological...
This is a delivery order federal contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the provision of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price of $1,023.13 and a performance period ending on May 29, 2025. The contract is not set-aside and was awarded on May 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECMY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,477.34, is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of May 19, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract is not designated as a set-aside.

Generated 8/15/25, 9:46 AM